Kling Bio Netherlands United Kingdom United States of America

Leverages Kling's technology to discover hard-to-find, immuno-functional antibodies from immortalized human B cells Accelerating discovery of first-in-class antibodies to transform disease prevention and treatmentView original content:https://www.prnewswire.co.uk/news-releases/kling-bio-announces-collaboration-with-sanofi-for-accelerated-discovery-of-neutralizing-antibodies-302512499.html